RIGL

Rigel Pharmaceuticals Stock Analysis

AI Rating

Great
  • Quality6/10
  • Growth↑ 9/10
  • Value↑ 8/10
Rigel Pharmaceuticals sales and earnings growth
RIGL Growth
Great
  • Revenue Y/Y↑ 64.15%
  • EPS Y/Y↑ 1960.61%
  • FCF Y/Y↑ 142.69%
Rigel Pharmaceuticals gross and profit margin trends
RIGL Profitability
Great
  • Gross margin ↑ 93.30%
  • EPS margin↑ 124.70%
  • ROIC 5Y↑ 21.58%
Rigel Pharmaceuticals net debt vs free cash flow
RIGL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.2
  • Interest coverage↑ 17.6

Rigel Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗